DAJY's Kunjin virus nucleic acid detection kit launched in Guangdong

Recently, the first nucleic acid test kit for Chikungunya virus in the country was approved for sale in Guangdong. It is reported that DAJY can increase its maximum production capacity to 10 million tests per day within one month as needed, fully ensuring the demand. On September 26, DAJY announced that the company recently obtained a medical device registration certificate issued by the National Medical Products Administration, with the medical device name being the Chikungunya virus nucleic acid test kit, valid from the date of approval until September 24, 2030. This test kit is used for the in vitro qualitative detection of Chikungunya virus nucleic acid in serum samples of suspected cases of Chikungunya fever and other cases requiring diagnosis or differential diagnosis of Chikungunya virus infection